Spok (NASDAQ:SPOK) Stock Price Passes Above 200 Day Moving Average – Here’s What Happened

Spok Holdings, Inc. (NASDAQ:SPOK)’s share price crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $15.68 and traded as high as $17.25. Spok shares last traded at $17.00, with a volume of 95,022 shares traded.

Wall Street Analysts Forecast Growth

Separately, StockNews.com upgraded shares of Spok from a “hold” rating to a “buy” rating in a research report on Friday, October 25th.

Spok Stock Performance

The stock has a market cap of $344.62 million, a price-to-earnings ratio of 23.29 and a beta of 0.33. The firm’s 50-day simple moving average is $16.20 and its two-hundred day simple moving average is $15.68.

Institutional Investors Weigh In On Spok

Several hedge funds and other institutional investors have recently added to or reduced their stakes in SPOK. SG Americas Securities LLC bought a new position in shares of Spok in the 3rd quarter valued at about $116,000. nVerses Capital LLC bought a new position in shares of Spok in the 3rd quarter valued at about $27,000. Quest Partners LLC bought a new position in shares of Spok in the 3rd quarter valued at about $473,000. Foundry Partners LLC boosted its stake in shares of Spok by 1.0% in the 3rd quarter. Foundry Partners LLC now owns 437,255 shares of the Wireless communications provider’s stock valued at $6,585,000 after purchasing an additional 4,120 shares during the last quarter. Finally, Kingsview Wealth Management LLC bought a new position in shares of Spok in the 3rd quarter valued at about $529,000. Institutional investors and hedge funds own 50.81% of the company’s stock.

About Spok

Spok Holdings, Inc, through its subsidiary, Spok, Inc, provides healthcare communication solutions in the United States, Europe, Canada, Australia, Asia, and the Middle East. The company's products and services enhance workflows for clinicians and support administrative compliance. It delivers clinical information to care teams when and where it matters to enhance patient outcomes; and provides GenA Pager, a one-way alphanumeric pager.